FY2025 · period end Dec '25 · from the 10-K filed Feb 13, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $14.73B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001324424-26-000042 | Jun 17, 2026 | Jun 23, 2026 | Jun 22, 2026 22:01 UTC | EDGAR |
| 10-Q | 0001324424-26-000035 | Mar 31, 2026 | May 8, 2026 | May 7, 2026 21:44 UTC | EDGAR |
| 8-K | 0001324424-26-000031 | May 7, 2026 | May 7, 2026 | May 7, 2026 20:02 UTC | EDGAR |
| 8-K | 0001324424-26-000016 | Apr 17, 2026 | Apr 23, 2026 | Apr 23, 2026 13:00 UTC | EDGAR |
| 8-K | 0001104659-26-042073 | Apr 8, 2026 | Apr 10, 2026 | Apr 10, 2026 20:33 UTC | EDGAR |
| 8-K | 0001104659-26-036875 | Mar 27, 2026 | Mar 30, 2026 | Mar 30, 2026 21:34 UTC | EDGAR |
| 10-K | 0001324424-26-000008 | Dec 31, 2025 | Feb 13, 2026 | Feb 12, 2026 22:40 UTC | EDGAR |
| 8-K | 0001324424-26-000005 | Feb 12, 2026 | Feb 12, 2026 | Feb 12, 2026 21:01 UTC | EDGAR |
Direct links to SEC EDGAR. EXPE has additional filings available on the SEC site.
Figures a later SEC filing revised from what was first reported. Each diff compares the same XBRL tag across two filings — both linked, so you can check it yourself.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·Q1 2011
Major restatementwas$74.2M
Revised down in a 10-Q.
Operating Income (Loss)·Q1 2011
Major restatementwas$108.2M
Revised down in a 10-K.
Operating Income (Loss)·Q1 2010
Major restatementwas$112.2M
Revised down in a 10-K.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·Q2 2011
Major restatementwas$196.3M
Revised down in a 10-Q.
Operating Income (Loss)·Q2 2011
Major restatementwas$227M
Revised down in a 10-K.
Operating Income (Loss)·Q2 2010
Major restatementwas$193.7M
Revised down in a 10-K.
EXPE is not the only one.
See every restatement we've found across the market — or get an alert the next time EXPE revises a number.
Restatements are detected by comparing every vintage of a fact across all of Expedia Group, Inc.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows EXPE's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling Expedia Group, Inc. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on EXPE yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on EXPE and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $12.84B |
| $11.67B |
| $8.60B |
| Gross Profit | $13.28B | $12.25B | $11.27B | $10.01B | $7.08B |
|---|
| Operating Income | $1.87B | $1.32B | $1.03B | $1.08B | $0.19B |
|---|
| Net Income | $1.30B | $1.22B | $0.69B | $0.34B | $0.01B |
|---|
| EPS (Diluted) | $9.81 | $8.95 | $5.31 | $2.17 | negative: -$1.80 |
|---|
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $24.45B | $22.39B | $21.64B | $21.56B | $21.55B |
| Total Liabilities | — | — | — | — | — |
| Stockholders' Equity | $2.55B | $2.80B | $2.79B | $3.73B | $3.55B |
| Cash & Equivalents | $5.41B | $5.57B | $5.66B | $5.85B | $5.80B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $3.88B | $3.08B | $2.69B | $3.44B | $3.75B |
| Capital Expenditures | $0.77B | $0.76B | $0.85B | $0.66B | $0.67B |
| Free Cash Flow | $3.11B | $2.33B | $1.84B | $2.78B | $3.08B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 90.1% | 89.5% | 87.7% | 85.8% | 82.3% |
| Operating Margin | 0.1% | 0.1% | 0.1% | 0.1% | 0.0% |
| Net Margin | 0.1% | 0.1% | 0.1% | 0.0% | 0.0% |
| Return on Equity | 48.7% | 43.8% | 21.1% | 9.4% | 0.5% |
| Return on Assets | 5.6% | 5.6% | 3.2% | 1.6% | 0.1% |
| Debt / Equity | 3.08× | 2.61× | 2.24× | 1.67× | 2.59× |
